Skip to main content
TipRanks
Go Ultimate75% OFF

CASI Pharmaceuticals (ENM) Q2 2021 Earnings Report

0 Followers

CH:ENM Q2 2021 EPS Results

Actual EPS
-CHF 0.42
Consensus EPS
-CHF 0.61
Beat/Miss
Beat by +CHF 0.19
One Year Ago EPS
-CHF 0.76

CH:ENM Q2 2021 Revenue Results

Actual Revenue
CHF 5.99M
Expected Revenue
CHF 5.06M
Beat/Miss
Beat by +CHF 927.35K
YoY Revenue Growth
+170.09%

Earnings Announcement Details

Quarter
Q2 2021
Date
08/12/2021
Time
Before Open
Conference Call
Thursday, August 12, 2021
CH:ENM Upcoming Earnings

CASI Pharmaceuticals's next earnings date is estimated for May 20, 2027, based on past reporting schedules.

Q2 2021 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2021 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2021 Earnings Call Summary

No earnings call summary is available for this earnings event.

CH:ENM Earnings History

CH:ENM earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
May 20, 20272027 (Q1)―-―――
Nov 13, 20262026 (Q3)―--0.57―
Aug 14, 20262026 (Q2)―-0.82-0.72-13.37% (-0.10)
May 14, 20262026 (Q1)―--0.58―
Apr 29, 20262025 (Q4)―--0.58―
Nov 14, 20252025 (Q3)-0.34-0.57-0.46-23.64% (-0.11)
Aug 29, 20252025 (Q2)-0.40-0.72-0.44-65.38% (-0.29)
May 16, 20252025 (Q1)―-0.58-0.62.82% (+0.02)
Mar 31, 20252024 (Q4)-0.51-0.58-0.62.82% (+0.02)
Nov 15, 20242024 (Q3)-0.52-0.46-0.29-57.14% (-0.17)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed